Global Herceptin Biosimilar Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Herceptin Biosimilar Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC5274825
  • Published Date :
    May 31, 2024
  • Number of Pages :
    350

Product Description

The Herceptin Biosimilar market was valued at US$ xx in 2023. The market for Herceptin Biosimilar is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Herceptin Biosimilar industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Herceptin Biosimilar by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Herceptin Biosimilar market are discussed.

The market is segmented by types: 
    Breast Cancer
    Colorectal Cancer
    Leukemia
    Lymphoma
    Other

It can be also divided by applications:
    Hospital & Clinics
    Oncology Centers
    Other

And this report covers the historical situation, present status and the future prospects of the global Herceptin Biosimilar market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    Amgen
    AryoGen Biopharma
    Biocon
    Celltrion
    Gedeon Richter
    Genor Biopharma
    Mabion
    Mylan
    Roche
    The Instituto Vital Brazil

Report Includes:
- xx data tables and xx additional tables
- An overview of global Herceptin Biosimilar market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Herceptin Biosimilar market
- Profiles of major players in the industry, including     Amgen,     AryoGen Biopharma,     Biocon,     Celltrion,     Gedeon Richter.....

Research objectives
    To study and analyze the global Herceptin Biosimilar consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031.
    To understand the structure of Herceptin Biosimilar market by identifying its various subsegments.
    Focuses on the key global Herceptin Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the Herceptin Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Herceptin Biosimilar submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content 

Table of Contents

Global Herceptin Biosimilar Market Report 2024, Forecast to 2031

1 Scope of the Study
    1.1 Herceptin Biosimilar Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 Herceptin Biosimilar Industry Overview
    2.1 Global Herceptin Biosimilar Market Size (Million USD) Comparison by Regions (2024-2031)
        2.1.1 Herceptin Biosimilar Global Import Market Analysis
        2.1.2 Herceptin Biosimilar Global Export Market Analysis
        2.1.3 Herceptin Biosimilar Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 Breast Cancer
        2.2.2 Colorectal Cancer
        2.2.3 Leukemia
        2.2.4 Lymphoma
        2.2.5 Other
    2.3 Market Analysis by Application
        2.3.1 Hospital & Clinics
        2.3.2 Oncology Centers
        2.3.3 Other
    2.4 Global Herceptin Biosimilar Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global Herceptin Biosimilar Sales and Market Share by Manufacturer (2019-2023)
        2.4.2 Global Herceptin Biosimilar Revenue and Market Share by Manufacturer (2019-2023)
        2.4.3 Global Herceptin Biosimilar Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 Herceptin Biosimilar Manufacturer Market Share
        2.4.5 Top 10 Herceptin Biosimilar Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into Herceptin Biosimilar Market
        2.4.7 Key Manufacturers Herceptin Biosimilar Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 Herceptin Biosimilar Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): Herceptin Biosimilar Industry Impact
        2.7.1 How the Covid-19 is Affecting the Herceptin Biosimilar Industry
        2.7.2 Herceptin Biosimilar Business Impact Assessment - Covid-19
        2.7.3 Market Trends and Herceptin Biosimilar Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 Herceptin Biosimilar Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Herceptin Biosimilar Market Size Categorized by Regions
    4.1 Global Herceptin Biosimilar Revenue, Sales and Market Share by Regions
        4.1.1 Global Herceptin Biosimilar Sales and Market Share by Regions (2019-2023)
        4.1.2 Global Herceptin Biosimilar Revenue and Market Share by Regions (2019-2023)
    4.2 Europe Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    4.3 APAC Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    4.4 North America Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    4.5 South America Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    4.6 Middle East & Africa Herceptin Biosimilar Sales and Growth Rate (2019-2023)

5 Europe Herceptin Biosimilar Market Size Categorized by Countries
    5.1 Europe Herceptin Biosimilar Sales, Revenue and Market Share by Countries
        5.1.1 Europe Herceptin Biosimilar Sales by Countries (2019-2023)
        5.1.2 Europe Herceptin Biosimilar Revenue by Countries (2019-2023)
        5.1.3 Germany Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        5.1.4 UK Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        5.1.5 France Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        5.1.6 Russia Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        5.1.7 Italy Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        5.1.8 Spain Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    5.2 Europe Herceptin Biosimilar Revenue (Value) by Manufacturers (2019-2023)
    5.3 Europe Herceptin Biosimilar Sales, Revenue and Market Share by Type (2019-2023)
        5.3.1 Europe Herceptin Biosimilar Sales Market Share by Type (2019-2023)
        5.3.2 Europe Herceptin Biosimilar Revenue and Revenue Share by Type (2019-2023)
    5.4 Europe Herceptin Biosimilar Sales Market Share by Application (2019-2023)

6 Asia-Pacific Herceptin Biosimilar Market Size Categorized by Countries
    6.1 Asia-Pacific Herceptin Biosimilar Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific Herceptin Biosimilar Sales by Countries (2019-2023)
        6.1.2 Asia-Pacific Herceptin Biosimilar Revenue by Countries (2019-2023)
        6.1.3 China Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        6.1.4 Japan Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        6.1.5 Korea Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        6.1.6 India Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        6.1.7 Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        6.1.8 Australia Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    6.2 Asia-Pacific Herceptin Biosimilar Sales and Revenue (Value) by Manufacturers (2019-2023)
    6.3 Asia-Pacific Herceptin Biosimilar Sales, Revenue and Market Share by Type (2019-2023)
        6.3.1 Asia-Pacific Herceptin Biosimilar Sales Market Share by Type (2019-2023)
        6.3.2 Asia-Pacific Herceptin Biosimilar Revenue and Revenue Share by Type (2019-2023)
    6.4 Asia-Pacific Herceptin Biosimilar Sales and Market Share by Application (2019-2023)

7 North America Herceptin Biosimilar Market Size Categorized by Countries
    7.1 North America Herceptin Biosimilar Sales, Revenue and Market Share by Countries
        7.1.1 North America Herceptin Biosimilar Sales by Countries (2019-2023)
        7.1.2 North America Herceptin Biosimilar Revenue by Countries (2019-2023)
        7.1.3 United States Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        7.1.4 Canada Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        7.1.5 Mexico Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    7.2 North America Herceptin Biosimilar Revenue (Value) by Manufacturers (2019-2023)
    7.3 North America Herceptin Biosimilar Sales, Revenue and Market Share by Type (2019-2023)
        7.3.1 North America Herceptin Biosimilar Sales Market Share by Type (2019-2023)
        7.3.2 North America Herceptin Biosimilar Revenue and Revenue Share by Type (2019-2023)
    7.4 North America Herceptin Biosimilar Sales Market Share by Application (2019-2023)

8 South America Herceptin Biosimilar Market Size Categorized by Countries
    8.1 South America Herceptin Biosimilar Sales, Revenue and Market Share by Countries
        8.1.1 South America Herceptin Biosimilar Sales by Countries (2019-2023)
        8.1.2 South America Herceptin Biosimilar Revenue by Countries (2019-2023)
        8.1.3 Brazil Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    8.2 South America Herceptin Biosimilar Revenue (Value) by Manufacturers (2019-2023)
    8.3 South America Herceptin Biosimilar Sales, Revenue and Market Share by Type (2019-2023)
        8.3.1 South America Herceptin Biosimilar Sales Market Share by Type (2019-2023)
        8.3.2 South America Herceptin Biosimilar Revenue and Revenue Share by Type (2019-2023)
    8.4 South America Herceptin Biosimilar Sales Market Share by Application (2019-2023)

9 Middle East and Africa Herceptin Biosimilar Market Size Categorized by Countries
    9.1 Middle East and Africa Herceptin Biosimilar Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Herceptin Biosimilar Sales by Countries (2019-2023)
        9.1.2 Middle East and Africa Herceptin Biosimilar Revenue by Countries (2019-2023)
        9.1.3 GCC Countries Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        9.1.4 Turkey Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        9.1.5 Egypt Herceptin Biosimilar Sales and Growth Rate (2019-2023)
        9.1.6 South Africa Herceptin Biosimilar Sales and Growth Rate (2019-2023)
    9.2 Middle East and Africa Herceptin Biosimilar Revenue (Value) by Manufacturers (2019-2023)
    9.3 Middle East and Africa Herceptin Biosimilar Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa Herceptin Biosimilar Sales Market Share by Type (2019-2023)
        9.3.2 Middle East and Africa Herceptin Biosimilar Revenue and Revenue Share by Type (2019-2023)
    9.4 Middle East and Africa Herceptin Biosimilar Sales Market Share by Application (2019-2023)

10 Global Herceptin Biosimilar Market Segment by Type
    10.1 Global Herceptin Biosimilar Revenue, Sales and Market Share by Type (2019-2023)
        10.1.1 Global Herceptin Biosimilar Sales and Market Share by Type (2019-2023)
        10.1.2 Global Herceptin Biosimilar Revenue and Market Share by Type (2019-2023)
    10.2 Breast Cancer Sales Growth Rate and Price
        10.2.1 Global Breast Cancer Sales Growth Rate (2019-2023)
        10.2.2 Global Breast Cancer Price (2019-2023)
    10.3 Colorectal Cancer Sales Growth Rate and Price
        10.3.1 Global Colorectal Cancer Sales Growth Rate (2019-2023)
        10.3.2 Global Colorectal Cancer Price (2019-2023)
    10.4 Leukemia Sales Growth Rate and Price
        10.4.1 Global Leukemia Sales Growth Rate (2019-2023)
        10.4.2 Global Leukemia Price (2019-2023)
    10.5 Lymphoma Sales Growth Rate and Price
        10.5.1 Global Lymphoma Sales Growth Rate (2019-2023)
        10.5.2 Global Lymphoma Price (2019-2023)
    10.6 Other Sales Growth Rate and Price
        10.6.1 Global Other Sales Growth Rate (2019-2023)
        10.6.2 Global Other Price (2019-2023)

11 Global Herceptin Biosimilar Market Segment by Application
    11.1 Global Herceptin BiosimilarSales Market Share by Application (2019-2023)
    11.2 Hospital & Clinics Sales Growth Rate (2019-2023)
    11.3 Oncology Centers Sales Growth Rate (2019-2023)
    11.4 Other Sales Growth Rate (2019-2023)

12 Market Forecast for Herceptin Biosimilar
    12.1 Global Herceptin Biosimilar Revenue, Sales and Growth Rate (2024-2031)
    12.2 Herceptin Biosimilar Market Forecast by Regions (2024-2031)
        12.2.1 Europe Herceptin Biosimilar Market Forecast (2024-2031)
        12.2.2 APAC Herceptin Biosimilar Market Forecast (2024-2031)
        12.2.3 North America Herceptin Biosimilar Market Forecast (2024-2031)
        12.2.4 South America Herceptin Biosimilar Market Forecast (2024-2031)
        12.2.5 Middle East & Africa Herceptin Biosimilar Market Forecast (2024-2031)
    12.3 Herceptin Biosimilar Market Forecast by Type (2024-2031)
        12.3.1 Global Herceptin Biosimilar Sales Forecast by Type (2024-2031)
        12.3.2 Global Herceptin Biosimilar Market Share Forecast by Type (2024-2031)
    12.4 Herceptin Biosimilar Market Forecast by Application (2024-2031)
        12.4.1 Global Herceptin Biosimilar Sales Forecast by Application (2024-2031)
        12.4.2 Global Herceptin Biosimilar Market Share Forecast by Application (2024-2031)

13 Analysis of Herceptin Biosimilar Industry Key Manufacturers
    13.1 Amgen
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 Amgen Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.1.4 Main Business Overview
        13.1.5 Amgen News
    13.2 AryoGen Biopharma
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 AryoGen Biopharma Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.2.4 Main Business Overview
        13.2.5 AryoGen Biopharma News
    13.3 Biocon
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 Biocon Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.3.4 Main Business Overview
        13.3.5 Biocon News
    13.4 Celltrion
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Celltrion Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.4.4 Main Business Overview
        13.4.5 Celltrion News
    13.5 Gedeon Richter
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Gedeon Richter Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.5.4 Main Business Overview
        13.5.5 Gedeon Richter News
    13.6 Genor Biopharma
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 Genor Biopharma Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.6.4 Main Business Overview
        13.6.5 Genor Biopharma News
    13.7 Mabion
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 Mabion Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.7.4 Main Business Overview
        13.7.5 Mabion News
    13.8 Mylan
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 Mylan Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.8.4 Main Business Overview
        13.8.5 Mylan News
    13.9 Roche
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Roche Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.9.4 Main Business Overview
        13.9.5 Roche News
    13.10 The Instituto Vital Brazil
        13.10.1 Company Details
        13.10.2 Product Information
        13.10.3 The Instituto Vital Brazil Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.10.4 Main Business Overview
        13.10.5 The Instituto Vital Brazil News

14 Research Findings and Conclusion

15 Appendix

Search results for Pharmaceutical Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Defense and Aeronautics

Pharmaceutical

Top Rated Products